The greater part of third quarter earnings results are in the rearview mirror, though investors this week are looking to reports from The Walt Disney Company and Alibaba . So far, ...
Sagimet Biosciences Inc. Phase 1 clinical trial to evaluate the PK of a combination of denifanstat and resmetirom ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback